Source:http://linkedlifedata.com/resource/pubmed/id/11035928
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2000-12-12
|
pubmed:abstractText |
The study of gene functions in complex genetic environments such as mammalian cells would greatly benefit from systems allowing a tight control of gene expression. The tetracycline-inducible gene expression system and the site-specific Cre/loxP recombination system have gained increasing popularity for conditional expression and gene disruption. To facilitate the analysis of gene functions in a cell autonomous system, we have established an F9 murine embryonal carcinoma cell line, constitutively expressing both the doxycycline-controlled transactivator rtTA and the tamoxifen-dependent Cre recombinase Cre-ER(T). The expression of a reporter gene placed under the control of tetracycline operators was induced about 1000-fold by doxycycline, and tamoxifen-induced excision of a loxP-flanked DNA segment occurred in all cells. This genetically engineered cell line, which allows, upon simple ligand addition, sophisticated genetic manipulations, such as sequential inactivation of loxP-flanked genes, and tightly controlled reexpression of their cDNAs, should be a valuable tool for studying mammalian gene functions.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Cre recombinase,
http://linkedlifedata.com/resource/pubmed/chemical/Doxycycline,
http://linkedlifedata.com/resource/pubmed/chemical/Integrases,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Estrogen,
http://linkedlifedata.com/resource/pubmed/chemical/Repressor Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Retinoids,
http://linkedlifedata.com/resource/pubmed/chemical/Tamoxifen,
http://linkedlifedata.com/resource/pubmed/chemical/Tetracycline,
http://linkedlifedata.com/resource/pubmed/chemical/Viral Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/tetracycline resistance-encoding...
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0014-4827
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright 2000 Academic Press.
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
260
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
334-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11035928-Carcinoma, Embryonal,
pubmed-meshheading:11035928-Doxycycline,
pubmed-meshheading:11035928-Gene Expression,
pubmed-meshheading:11035928-Genetic Engineering,
pubmed-meshheading:11035928-Humans,
pubmed-meshheading:11035928-Integrases,
pubmed-meshheading:11035928-Mutagenesis, Site-Directed,
pubmed-meshheading:11035928-Receptors, Estrogen,
pubmed-meshheading:11035928-Repressor Proteins,
pubmed-meshheading:11035928-Retinoids,
pubmed-meshheading:11035928-Tamoxifen,
pubmed-meshheading:11035928-Tetracycline,
pubmed-meshheading:11035928-Tumor Cells, Cultured,
pubmed-meshheading:11035928-Viral Proteins
|
pubmed:year |
2000
|
pubmed:articleTitle |
F9 embryonal carcinoma cells engineered for tamoxifen-dependent Cre-mediated site-directed mutagenesis and doxycycline-inducible gene expression.
|
pubmed:affiliation |
Institut de Génétique et de Biologie Moléculaire et Cellulaire, Illkirch-Cedex, 67404, France.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|